A double masked randomised 4-week, placebo-controlled study in the USA, Thailand and Taiwan to compare the efficacy of oral valganciclovir and topical 2% ganciclovir in the treatment of cytomegalovirus anterior uveitis: study protocol

INTRODUCTION: Cytomegalovirus (CMV) anterior uveitis is a recognised cause of anterior uveitis in immunocompetent patients and is preventable cause of vision loss. Ocular sequelae include corneal endothelial damage which can cause corneal oedema and failure, as well as glaucoma. Recurrences of infla...

Descripción completa

Detalles Bibliográficos
Autores principales: Takhar, Jaskirat S, Joye, Ashlin S, Somkijrungroj, Thanapong, Laovirojjanakul, Wipada, Lin, Chang-Ping, Lietman, Thomas M, Porco, Travis C, Keenan, Jeremy D, Gebreegziabher, Elisabeth A, Seitzman, Gerami D, Rose-Nussbaumer, Jennifer, Doan, Thuy A, Acharya, Nisha R, Gonzales, John A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937053/
https://www.ncbi.nlm.nih.gov/pubmed/31862739
http://dx.doi.org/10.1136/bmjopen-2019-033175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937053/
https://www.ncbi.nlm.nih.gov/pubmed/31862739
http://dx.doi.org/10.1136/bmjopen-2019-033175

Ejemplares similares